Press Release | October 3, 2022
Metagenomi Announces Opening of Manufacturing Facility for its Next Generation CRISPR Gene-Editing Systems and Therapies
Read More
News | September 22, 2022
Affini-T Therapeutics Named to the 2022 Endpoints 11
Read More
News | September 22, 2022
Metagenomi Named an Endpoints 11 Winner
Read More
News | September 21, 2022
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
Read More
